[(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate

C49H85N3O18P2 — CID 157001085

IUPAC[(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate
SMILESCCCCC[C@H](O)/C=C/[C@@H]1[C@H](O)[C@H](O)[C@H]2COP(=O)(O)OP(=O)(O)OC[C@H](OC(=O)CCCCCCCCCCCCC(C)CC)COC(=O)CCC/C=C\C[C@H]([C@H](n3ccc(N)nc3=O)O2)[C@@H](O)C[C@H]1O
InChIInChI=1S/C49H85N3O18P2/c1-4-6-17-23-36(53)27-28-38-40(54)31-41(55)39-24-19-15-16-20-25-44(56)65-32-37(68-45(57)26-21-14-12-10-8-7-9-11-13-18-22-35(3)5-2)33-66-71(61,62)70-72(63,64)67-34-42(47(59)46(38)58)69-48(39)52-30-29-43(50)51-49(52)60/h15,19,27-30,35-42,46-48,53-55,58-59H,4-14,16-18,20-26,31-34H2,1-3H3,(H,61,62)(H,63,64)(H2,50,51,60)/b19-15-,28-27+/t35?,36-,37+,38-,39-,40+,41-,42+,46-,47+,48+/m0/s1
InChIKeyODUTWGIGHXISFW-LZAPQBQESA-N
MW1066.17 g/mol
LogP6.85
Rot. Bonds22

About [(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate

[(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate (PubChem CID 157001085) has the molecular formula C49H85N3O18P2 and a molecular weight of 1066.17 g/mol. Its IUPAC name is [(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate.

Molecular Properties

Compound Name[(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate
PubChem CID157001085
Molecular FormulaC49H85N3O18P2
Molecular Weight1066.17 g/mol
Exact Mass1065.53
IUPAC Name[(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate
SMILESCCCCC[C@H](O)/C=C/[C@@H]1[C@H](O)[C@H](O)[C@H]2COP(=O)(O)OP(=O)(O)OC[C@H](OC(=O)CCCCCCCCCCCCC(C)CC)COC(=O)CCC/C=C\C[C@H]([C@H](n3ccc(N)nc3=O)O2)[C@@H](O)C[C@H]1O
InChIInChI=1S/C49H85N3O18P2/c1-4-6-17-23-36(53)27-28-38-40(54)31-41(55)39-24-19-15-16-20-25-44(56)65-32-37(68-45(57)26-21-14-12-10-8-7-9-11-13-18-22-35(3)5-2)33-66-71(61,62)70-72(63,64)67-34-42(47(59)46(38)58)69-48(39)52-30-29-43(50)51-49(52)60/h15,19,27-30,35-42,46-48,53-55,58-59H,4-14,16-18,20-26,31-34H2,1-3H3,(H,61,62)(H,63,64)(H2,50,51,60)/b19-15-,28-27+/t35?,36-,37+,38-,39-,40+,41-,42+,46-,47+,48+/m0/s1
InChIKeyODUTWGIGHXISFW-LZAPQBQESA-N
XLogP6.85
TPSA326.18 Ų
H-Bond Donors8
H-Bond Acceptors19
Rotatable Bonds22
Heavy Atoms72
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001066.17
LogP ≤ 56.85
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate?
The IUPAC name of [(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate (CID 157001085) is [(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate.
What is the SMILES notation for [(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate?
The canonical SMILES for [(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate is CCCCC[C@H](O)/C=C/[C@@H]1[C@H](O)[C@H](O)[C@H]2COP(=O)(O)OP(=O)(O)OC[C@H](OC(=O)CCCCCCCCCCCCC(C)CC)COC(=O)CCC/C=C\C[C@H]([C@H](n3ccc(N)nc3=O)O2)[C@@H](O)C[C@H]1O.
What is the InChIKey of [(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate?
The InChIKey is ODUTWGIGHXISFW-LZAPQBQESA-N. The full InChI is InChI=1S/C49H85N3O18P2/c1-4-6-17-23-36(53)27-28-38-40(54)31-41(55)39-24-19-15-16-20-25-44(56)65-32-37(68-45(57)26-21-14-12-10-8-7-9-11-13-18-22-35(3)5-2)33-66-71(61,62)70-72(63,64)67-34-42(47(59)46(38)58)69-48(39)52-30-29-43(50)51-49(52)60/h15,19,27-30,35-42,46-48,53-55,58-59H,4-14,16-18,20-26,31-34H2,1-3H3,(H,61,62)(H,63,64)(H2,50,51,60)/b19-15-,28-27+/t35?,36-,37+,38-,39-,40+,41-,42+,46-,47+,48+/m0/s1.
What are the key properties of [(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate?
[(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate has a molecular weight of 1066.17 g/mol, XLogP of 6.85, 22 rotatable bonds, 8 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R,9R,16Z,19S,20S,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,20,22,24,25-hexahydroxy-23-[(E,3S)-3-hydroxyoct-1-enyl]-4,6,12-trioxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 14-methylhexadecanoate is sourced from PubChem (CID 157001085), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).